Top Markets
#1 Pleasing Gold Pleasing Gold +601.27%
#2 Islamic Coin Islamic Coin +154.11%
#3 PulseChain PulseChain +52.83%
#4 BOOK OF MEME BOOK OF MEME +48.28%
#5 DogBull DogBull +37.09%
#6 Nockchain Nockchain +24.64%
#7 ORDI ORDI +19.01%
#8 Monad Monad +18.58%
#9 SkyAI SkyAI +16.70%
#10 Neiro Neiro +16.45%
Coin of the day
Pleasing Gold Pleasing Gold
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Pharmarise Holdings Corporation Pharmarise Holdings Corporation

Pharmarise Holdings Corporation

2796
Classement en actions #26825
Pharmarise Holdings Corporation predominantly oversees a chain of pharmacies... Pharmarise Holdings Corporation predominantly oversees a chain of pharmacies that dispense prescription medications throughout Japan. These establishments fulfill prescriptions provided by medical facilities, offering vital pharmaceutical services to patients. Beyond its primary dispensing activities, the company also manages drugstores and convenience stores, and retails cosmetic products. Additionally, it provides services including the safekeeping and administration of patient medical records for healthcare institutions, operates medical complex centers, and offers temporary staffing assistance. As of May 31, 2021, the corporation maintained a network of 347 outlets. Pharmarise Holdings Corporation was founded in 1984 and its main office is located in Tokyo, Japan.
Prix de l'action
$3.26
Capitalisation boursière
$37.45M
Changement (1 jour)
0.40%
Changement (1 an)
-4.06%
Pays
JP
Échange Pharmarise Holdings Corporation (2796)

Catégorie

Healthcare
Bénéfices pour Pharmarise Holdings Corporation (2796)
Bénéfices en 2026 TTM : 0
Selon les derniers rapports financiers de Pharmarise Holdings Corporation, les bénéfices actuels de l'entreprise sont de 0. En 2026, l'entreprise a réalisé un bénéfice de 0, égal à celui de 2026 qui était de 0. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour Pharmarise Holdings Corporation de 2026 à 2026
Bénéfices à la fin de chaque année
Année Bénéfices Changez
Pas assez de données pour les dates fournies.
Bénéfices des entreprises similaires ou concurrentes
Entreprise Bénéfices Différence de bénéfices Pays
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
$26.37M -
US
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT